2029 in pharma — approvals, patent cliffs, Phase 3 readouts

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 2029: 0 approvals, 183 patent expiries, 0 Phase 3 milestones.

202720282029

FDA / EMA / MHRA approvals (0)

No entries tracked.

Patent expiries (183)

Phase 3 readouts (0)

No entries tracked.